Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_05a203d85ee01909eaf728dc16f0f6cb |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H15-22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H15-26 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H15-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-6867 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-6807 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-64 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H15-26 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-68 |
filingDate |
2018-01-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bbb559d55ead99b62fb7dc5c60bea2ae http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b6005a14c06ea238b631c8a612857ee4 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2b083ff3322e9197d3c1d91a26810a5b http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1b11c303649f365a3108a7e930a4ab52 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_eba58fe2bc8a738c10f3388ea9e41873 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b16449a195e8b8c9a299e56bfedbce0a http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_45b05bc54735e3024d26477cb2dbb3ce http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0564aa51f49240eb27f5b661b9e261fb http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a374dab69b931cb22c3d60c3aec283ad |
publicationDate |
2019-11-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-2019345186-A1 |
titleOfInvention |
Calicheamicin deratives and antibody drug conjugates thereof |
abstract |
The present invention is directed to novel calicheamicin derivatives useful as payloads in antibody-drug-conjugates (ADC's), and to payload-linker compounds and ADC compounds comprising the same; to pharmaceutical compositions comprising the same and to methods for using the same to treat pathological conditions such as cancer. |
priorityDate |
2017-01-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |